Literature DB >> 10975820

Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.

A J McAdam1, B E Gewurz, E A Farkash, A H Sharpe.   

Abstract

B7-1 and B7-2 are important costimulatory molecules in the activation of T cell immunity. We have used mice made genetically deficient in either or both B7 molecules to determine the role of B7 molecules in activation of primary alloreactive CTL. The absence of either B7-1 or B7-2 did not alter generation of CTL from unfractionated lymphocytes, but the absence of B7-2 greatly decreased CTL generation from purified CD8+ responder cells. However, if B7-1 was induced on the stimulating cells then CTL generation was restored to wild-type levels. Absence of both B7-1 and B7-2 from MLR using whole splenocytes resulted in a profound reduction in generation of CTL. This could completely be reversed by the addition of IL-2. B7 molecules could directly costimulate CD8+ cells, as purified CD8+ cells developed into mature CTL when stimulated with wild-type APC, but not with B7-deficient APC. Again, IL-2 could drive CTL generation from purified CD8+ cells, even in the absence of B7 molecules. Taken together, these results demonstrate an important role for B7 costimulation in CTL generation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975820     DOI: 10.4049/jimmunol.165.6.3088

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules.

Authors:  Kathy A Green; W James Cook; Arlene H Sharpe; William R Green
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Authors:  Osamu Imataki; Sascha Ansén; Makito Tanaka; Marcus O Butler; Alla Berezovskaya; Matthew I Milstein; Kiyotaka Kuzushima; Lee M Nadler; Naoto Hirano
Journal:  J Immunol       Date:  2012-01-11       Impact factor: 5.422

Review 3.  CD28 function: a balance of costimulatory and regulatory signals.

Authors:  Hélène Bour-Jordan; Jeffrey A Blueston
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

4.  Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.

Authors:  Shahram Salek-Ardakani; Ramon Arens; Rachel Flynn; Alessandro Sette; Stephen P Schoenberger; Michael Croft
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.

Authors:  O Toker; M Berger; O Shamriz; A J Simon; A Lev; O Megged; O Ledder; E Picard; L Joseph; V Molho-Pessach; Y Tal; P Millman; M Slae; R Somech
Journal:  Clin Exp Immunol       Date:  2020-04-18       Impact factor: 4.330

6.  CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.

Authors:  Melanie S Vacchio; Richard J Hodes
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.